A comprehensive view of Citigroup Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pulp & Paper Industry Market Intelligence Service.
Citi rates James Hardie at buy, as fiscal Q4 adjusted net income and 2025 guidance fall short of forecasts, driven by rising advertising spend; Citi concerned by lack of flexibility around SG&A spend, which is negatively impacting near-term profitability
Published:
May 20, 2024
by FN Arena
|
Beacon Roofing Supply signs US$225M accelerated share repurchase agreement with Citibank, expected to finalize in Q4; buyback is part of its ongoing shareholder value creation strategy and Ambition 2025 plan
Published:
May 13, 2024
by Business Wire
|
Citi rates Novo Nordisk at buy, expecting its sales to grow by 27% in 2024, as price of GLP-1 drugs fall and clinical data support their use; Novo has 12 million patients on GLP-1 drugs, while addressable population for treatment approaches 1 billion
Published:
May 08, 2024
by Proactive Investors
|
Citi upgrades Target to buy from neutral and names it one of retail sector's winners after a choppy few years, citing well-controlled inventory, easier sales comparisons, conservative guidance and new membership program
Published:
May 07, 2024
by Schaeffer's Daily Contrarian
|
Citigroup CEO notes US consumers are spending less, struggling with loan payments, causing banks to tread cautiously on unsecured lending
Published:
May 06, 2024
by Global Banking News
|
Ask us about our Pulp & Paper Industry market view